Compare Rush Street Interactive Inc (RSI) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rush Street Interactive Inc vs Twist Bioscience Corp — how do they compare? Rush Street Interactive Inc trades at $19.27 (market cap $2.35B), while Twist Bioscience Corp trades at $162.26 (market cap $10.08B). The key difference: Twist Bioscience Corp is far larger — about 4.3× Rush Street Interactive Inc's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Rush Street Interactive Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rush Street Interactive Inc for 13 Days and Twist Bioscience Corp for 27 Days on average.
| RSI | TWST | |
|---|---|---|
Market Cap | $2.35B | $10.08B |
Volume | 2,219,374 | 4,229,037 |
Sector | Consumer Cyclical | Health |
52-Week High | $34.52 | $205.00 |
52-Week Low | $15.89 | $25.45 |
Typical Hold Time | 13 Days | 27 Days |
Enterprise Value | $2.01B | $10.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RSI trades at $19.89, down 1.73% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 EPS of $0.15, beating estimates, and revenue growth to $1.4 billion projected for 2026. Analyst consensus is strongly bullish with a $34.88 price target, though net income margins remain thin at 2.33%.
The stock presents a mixed outlook: strong analyst support and revenue growth contrast with high valuation multiples and bearish technical trends. Key risks include competitive pressures in online gaming and reliance on sports betting cycles. Upside depends on margin improvement and execution of growth initiatives.
TWST trades at $155.65, down 6.78% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $377M in 2025, but the company remains unprofitable with a net income margin of -31.66%. Recent news highlights its role in Eli Lilly's AI-driven drug discovery platform, boosting sentiment despite earnings misses.
The outlook is mixed: analyst consensus is bullish with a $145.20 price target, but high valuation multiples and persistent losses pose risks. Investment opportunity hinges on AI partnerships driving future profitability, while execution risks and cash burn require careful monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
